Hemodialysis and Peritoneal Dialysis Market for Hemodialysis Segment to Grow Significantly During 2021-2028

According to our new research study on "Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Product, and End User," the market is expected to grow from US$ 84,610.62 million in 2021 to US$ 130,370.18 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028. The report highlights trends prevailing in the market and factors governing the growth of the hemodialysis and peritoneal dialysis market. Increasing incidence of chronic kidney diseases propel the market growth. However, risks and complications associated with dialysis limit the market growth.

According to the National Kidney Foundation report, 10% of the population globally is affected by chronic kidney disease (CKD), and millions die annually owing to having access to affordable treatment. Additionally, over 2 million people worldwide currently receive treatment with dialysis to stay alive. Hemodialysis (HD) is the most common renal replacement therapy (RRT) modality practiced worldwide. For example, the number of HD stations in India was estimated to be 12,881 in 2018. The Union Government announced a National Dialysis Program in 2016 focusing on setting up eight-station dialysis facilities in 688 districts in India, offering HD to poor patients. Further, the Centers for Disease Control and Prevention (CDC) report states that ~ 36 million adults are suffering from chronic kidney diseases (CKD) in the US. Every 24 hours, 360 people begin dialysis treatment for kidney failure. Moreover, in the past few years, the requirement for dialysis has increased stupendously. Therefore, the increasing prevalence of End-Stage Renal Disease (ESRD) drives the adoption of hemodialysis and peritoneal dialysis.

Increasing adoption of self-care dialysis and rising initiatives by competitive players for introducing advanced products and services propel the growth of the hemodialysis and peritoneal dialysis market. According to the report by the American Association of Kidney Patients (AAKP), self-care (home) dialysis therapies, such as peritoneal dialysis and home hemodialysis, are receiving significant attention for patients suffering from CKD across the world. Also, the adoption of hemodialysis and peritoneal dialysis as effective therapies and treatments for patients suffering from ESRD is increasing. Therefore, if self-care benefits are identified, it may prove as one of the remarkable therapy options for patients suffering from CKD that may include improved healthcare outcomes.

Rising number of strategies by leading players in the hemodialysis and peritoneal dialysis market drives the overall market growth. For instance, in December 2020, Medtronic announced the launch of the first and only pediatric and neonatal acute dialysis machine in the US. The newly launched product, namely "Carpediem" system, is designed for treating patients requiring renal replacement therapy weighing between 2.5 and 10 kilograms (5.5 to 22 pounds). The newly launched product has been successfully installed and is used in Cincinnati Children's Hospital Medical Center.

Based on type, the hemodialysis and peritoneal dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment led the market in 2021 and is expected to retain its dominance during the forecast period. Hemodialysis, also known as "haemo," is a dialysis treatment recommended for kidney failure patients. According to the statistics revealed by the University of California San Francisco, nearly 750,000 patients in the US and an estimated two million patients globally suffer from kidney failure on an annual basis. Hemodialysis is a recommended procedure for patients suffering from kidney (or renal) failure and is performed among 90% of all dialysis patients worldwide. As per the University of California San Francisco report, 35% of hemodialysis patients remain alive for almost 5 years after treatment.

Furthermore, a report by the Department of Health & Human Services USA states that the U.S. Food and Drug Administration has approved devices for home hemodialysis and actively supports innovations in medical devices, intended for hemodialysis through its breakthrough programs and participation in "KidneyX," the Kidney Innovation Accelerator. The report further states that 87% of Americans suffering from kidney failure start their treatment with hemodialysis. The United States Renal Data System (US RDS) data revealed that about 63.1% of all prevalent End-Stage Renal Disease (ESRD) patients received hemodialysis therapy in 2016. These factors are significantly responsible for the segmental growth in the global hemodialysis and the peritoneal dialysis market, ultimately contributing to the overall market's development during the forecast period. Such aforementioned factors support the growth of the hemodialysis and peritoneal dialysis market for the hemodialysis segment.

Fresenius Medical Care AG & Co KGaA; Davita Inc.; Baxter International Inc.; B. Braun Melsungen AG; Diaverum; Nipro Medical Corporation; Evoqua Water Technologies LLC. (Mar Cor Purification); Asahi Kasei Medical Co., Ltd.; Rockwell Medical, Inc.; and Dialife SA are among the leading companies operating in the hemodialysis and peritoneal dialysis market.

The report segments the hemodialysis and peritoneal dialysis market as follows:

The hemodialysis and peritoneal dialysis market is segmented on the basis of type, product, end user, and geography. The market, by type, is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis and peritoneal dialysis market, based on product, is segmented into devices, consumables, and services. The market, based on end user, is segmented into hospital-based and home-based. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com